Improved robotic surgery for advanced prostate cancer
Official title: Improved Robotic-Assisted Radical Prostatectomy for Locally Advanced Prostate Cancer: Bladder Suspension and Preliminary Outcomes
Run by First Affiliated Hospital of Fujian Medical University · NCT06977906 · Data updated 2026-11-12
This study tests a new robotic surgery technique for advanced prostate cancer to see if it helps improve recovery and urinary control compared to standard methods.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | Men only |
| Enrollment | 300 (estimated) |
| Sponsor | First Affiliated Hospital of Fujian Medical University Academic / other |
| Locations | 1 site (Fuzhou, Fujian) |
| Status | Recruiting |
| Started | January 1, 2024 |
| Main results expected | January 1, 2027 |
| Study ends | January 1, 2027 |
| Registry record updated | May 18, 2025 |
| Trial ID | NCT06977906 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include men with high-risk prostate cancer confirmed by biopsy and imaging, who are in good general health and can undergo robotic-assisted surgery.
✕Probably not a fit
Patients with surgical contraindications or those who refuse enhanced imaging may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates an enhanced technique for robotic-assisted radical prostatectomy aimed at treating locally advanced prostate cancer. The study focuses on the impact of preserving the anterior peritoneum of the bladder on postoperative outcomes, particularly bladder descent and urinary control recovery. It compares this modified approach with traditional surgical methods through a prospective, single-center design, assessing oncological outcomes, functional recovery, and complication rates. The findings aim to provide new insights and technical support for managing postoperative urinary incontinence.
Why it matters
Potential benefit: If successful, this approach could lead to improved urinary control and reduced complications for patients undergoing prostate cancer surgery.
How similar studies have gone: While similar robotic-assisted surgical techniques have shown promise, this specific approach is novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. prostate biopsy and clinical confirmation of high-risk prostate cancer (PSA \> 20 ng/mL, Gleason score ≥ 8, or cT stage ≥ T2c) followed by robotic-assisted radical prostatectomy 2. multiparametric MRI (mpMRI) with a 3.0 T scanner for prostate or pelvic scans performed within 30 days before the operation at our center 3. Eastern Cooperative Oncology Group (ECOG) performance status score between 0 and 1 4. Complete clinical and prostate biopsy pathological data. 5. General health is good, with no infections, autoimmune diseases, hematologic disorders, or other malignancies. Exclusion Criteria: 1. Presence of surgical contraindications. 2. refusal of enhanced mpMRI imaging.
Where it's running
-
first hospital affiliated of Fujian medical university
Fuzhou, Fujian, China Recruiting
Study contacts
- Study coordinator: Xu Ning, Dr.
- Email: drxun@fjmu.edu.cn
- Phone: +8613235907575
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Targeted tumor boost and shortened radiation schedules for prostate cancer
This trial tests whether giving a higher radiation dose to the tumor inside the prostate (a focal boost) and delivering treatment in 12 instead of 20 sessions helps men with intermediate- or high-risk prostate cancer have fewer relapses and need less hormonal therapy.
-
Combining Pluvicto with radiation therapy for advanced prostate cancer
This study is testing if combining the drug Pluvicto with radiation therapy can help people with advanced prostate cancer reduce the chance of their cancer coming back while keeping their quality of life intact.
-
Genomic biomarker-guided therapy for advanced prostate cancer
This study is testing if personalized treatment based on genetic markers can help men with advanced prostate cancer before surgery.
-
Database for robotic-assisted prostate cancer surgeries
This study is gathering information from hospitals to see how well robotic surgeries for prostate cancer work and how they compare to traditional surgeries for patients in Australia.
-
Combining relugolix and enzalutamide for high-risk prostate cancer treatment
This study is testing if combining two medications, relugolix and enzalutamide, can help men with high-risk prostate cancer do better with their treatment and live longer.
-
Intense hormone therapy before surgery for advanced prostate cancer
This study is testing whether a stronger hormone treatment before surgery can help men with advanced prostate cancer do better than the usual hormone therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.